Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples